These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3299955

  • 1. [The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden].
    Povlsen UJ, Noring U, Meidahl B, Korsgaard S, Waehrens J, Gerlach J.
    Ugeskr Laeger; 1987 Jun 15; 149(25):1682-5. PubMed ID: 3299955
    [No Abstract] [Full Text] [Related]

  • 2. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
    Psychopharmacology (Berl); 1986 Jun 15; 90(4):423-9. PubMed ID: 2880362
    [Abstract] [Full Text] [Related]

  • 3. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
    Gerlach J, Simmelsgaard H.
    Psychopharmacology (Berl); 1978 Oct 31; 59(2):105-12. PubMed ID: 103110
    [No Abstract] [Full Text] [Related]

  • 4. [Bethanechol as treatment for urinary retention induced by a combination of neuroleptics and anticholinergics].
    Seguí Montesinos J, García Parés G, de Pablo Rabassó J.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985 Oct 31; 13(6):402-5. PubMed ID: 2871697
    [No Abstract] [Full Text] [Related]

  • 5. Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
    Kenney C, Hunter C, Davidson A, Jankovic J.
    J Clin Pharmacol; 2008 Mar 31; 48(3):379-84. PubMed ID: 18223146
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
    Barcia D, Pozo P, Ruiz ME, Forcadell F, Morcillo L, Soria JM, Carrasco E.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987 Mar 31; 15(1):25-8. PubMed ID: 3577874
    [No Abstract] [Full Text] [Related]

  • 7. Extrapyramidal side effects and tolerability of risperidone: a review.
    Owens DG.
    J Clin Psychiatry; 1994 May 31; 55 Suppl():29-35. PubMed ID: 7520906
    [Abstract] [Full Text] [Related]

  • 8. [20 years experience with chlorprothixene (author's transl)].
    Ravn J, Scharff A, Aaskoven O.
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Jan 31; 13(1):34-40. PubMed ID: 7367466
    [Abstract] [Full Text] [Related]

  • 9. Priapism and neuroleptics: a case report.
    Morera A, Estrada AG, Valenciano R.
    Acta Psychiatr Scand; 1988 Jan 31; 77(1):111-2. PubMed ID: 3348090
    [Abstract] [Full Text] [Related]

  • 10. Atypical and typical neuroleptics and tardive dyskinesia.
    Borison RL, Shah C, White TH, Diamond BI.
    Psychopharmacol Bull; 1987 Jan 31; 23(1):218-20. PubMed ID: 3602323
    [No Abstract] [Full Text] [Related]

  • 11. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb 31; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 12. [Tardive dyskinesia: an increased risk of neuroleptics in elderly women].
    Jessurun AY, Stek ML.
    Tijdschr Gerontol Geriatr; 1995 Oct 31; 26(5):197-9. PubMed ID: 8750979
    [Abstract] [Full Text] [Related]

  • 13. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Oct 31; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic-related dyskinesias in autistic children: a prospective study.
    Perry R, Campbell M, Green WH, Small AM, Die Trill ML, Meiselas K, Golden RR, Deutsch SI.
    Psychopharmacol Bull; 1985 Oct 31; 21(1):140-3. PubMed ID: 3885290
    [No Abstract] [Full Text] [Related]

  • 15. The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
    Turunen S, Achté KA.
    Psychiatr Q; 1967 Oct 31; 41(2):268-79. PubMed ID: 4383787
    [No Abstract] [Full Text] [Related]

  • 16. Haloperidol for acute psychiatric emergencies: a double-blind comparison with perphenazine in acute alcoholic psychosis.
    Ritter RM, Davidson DE.
    South Med J; 1971 Feb 31; 64(2):249-50. PubMed ID: 4927220
    [No Abstract] [Full Text] [Related]

  • 17. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):237-40. PubMed ID: 826968
    [Abstract] [Full Text] [Related]

  • 18. Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study.
    Greil W, Haag H, Rossnagl G, Rüther E.
    Br J Psychiatry; 1984 Sep 24; 145():304-10. PubMed ID: 6148119
    [Abstract] [Full Text] [Related]

  • 19. [Malignant syndrome caused by neuroleptics. Rapid response to biperiden in a case of brief development].
    Castilla Cortázar A, Alonso Alonso JJ, Aguirre Errasti C.
    Med Clin (Barc); 1985 Apr 13; 84(14):588. PubMed ID: 3999842
    [No Abstract] [Full Text] [Related]

  • 20. Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperiden.
    Oka M, Yamada K, Kamei C, Yoshida K, Shimizu M.
    Jpn J Pharmacol; 1979 Jun 13; 29(3):435-45. PubMed ID: 43913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.